Infinimmune
Infinimmune is pioneering the development of drugs from complete human antibodies, utilizing its unique Complete Human™ technology and the Anthrobody™ platform. The company focuses on discovering, characterizing, and advancing therapeutic antibodies that are fully human, aiming to treat human diseases such as autoimmunity and cancer. Their approach emphasizes safety, efficacy, and the potential for novel therapeutics by leveraging the human immune system's natural responses.
Industries
Nr. of Employees
small (1-50)
Products
Validated interleukin program (autoimmunity)
Preclinical-stage therapeutic antibody program targeting an interleukin pathway for autoimmune disease; listed as a validated interleukin program in the company's pipeline.
Immuno-oncology discovery programs (undisclosed targets)
Discovery-stage programs applying human repertoire sequencing and analysis to identify antibody therapeutics for oncology indications; targets not publicly disclosed.
Validated interleukin program (autoimmunity)
Preclinical-stage therapeutic antibody program targeting an interleukin pathway for autoimmune disease; listed as a validated interleukin program in the company's pipeline.
Immuno-oncology discovery programs (undisclosed targets)
Discovery-stage programs applying human repertoire sequencing and analysis to identify antibody therapeutics for oncology indications; targets not publicly disclosed.
Services
Collaborative antibody discovery and deep sequencing partnerships
Partnership engagements to perform deep B-cell sequencing and joint discovery of human-derived antibody candidates for therapeutic programs.
AI-driven antibody engineering (model-based design)
Machine-learning model trained on human antibody sequences to support antibody humanization, optimization, and sequence design workflows.
Collaborative antibody discovery and deep sequencing partnerships
Partnership engagements to perform deep B-cell sequencing and joint discovery of human-derived antibody candidates for therapeutic programs.
AI-driven antibody engineering (model-based design)
Machine-learning model trained on human antibody sequences to support antibody humanization, optimization, and sequence design workflows.
Expertise Areas
- Therapeutic antibody discovery from human repertoires
- AI-driven antibody engineering and optimization
- Protein engineering and alternate antibody formats
- Single-cell and deep B-cell sequencing
Key Technologies
- Immunosequencing (B-cell repertoire sequencing)
- Single-cell sequencing
- Deep B-cell sequencing
- AI / machine learning for antibody design